ProCE Banner Series

Transforming Cardiorenal Care: Nurse-Led Strategies for Heart Failure Management With SGLT2 Inhibitors

This symposium will explore nurse-led strategies to optimize heart failure management through the integration of SGLT2 inhibitors, highlighting their role in improving cardiorenal outcomes. Led by 2 expert faculty members, the session will provide practical, evidence-based insights to empower nurses in advancing patient care across diverse settings.

Who Should Attend

This activity is intended for cardiology nurses and nurse practitioners, including those specializing in heart failure, who care for patients with heart failure.

All Events

Transforming Cardiorenal Care: Nurse-Led Strategies for Heart Failure Management With SGLT2 Inhibitors

Upcoming Events

June

12

2025

7:15 AM - 8:30 AM Eastern Time (ET)

In-person

Savannah Convention Center, 1 International Drive, Savannah, Georgia 31421

7:30 AM - 8:30 AM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Heart Failure.

Target Audience
This activity is intended for cardiology nurses and nurse practitioners, including those specializing in heart failure, who care for patients with heart failure.

Learning Objectives
Upon completion of this activity, participants should be able to:

  •  Identify gaps in heart failure management guideline-directed medical therapy to improve patient outcomes

  •  Assess the benefits and safety of early and long-term use of SGLT2 inhibitors in heart failure care, focusing on their role in improving cardiovascular outcomes for eligible patients

  • Formulate nurse-led strategies to incorporate SGLT2 inhibitors into patient-centered treatment plans considering diverse presentations of left ventricular ejection fraction

Accreditation

This educational activity is not certified for CME/CE credit.

Acknowledgement

Provided by

Provided by Partners for Advancing Clinical Education (Partners)

Partners for Advancing Clinical Education (PACE) 2025

Supporters

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191